Archives of physical medicine and rehabilitation
-
Arch Phys Med Rehabil · Sep 2009
Randomized Controlled TrialA preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke.
To determine if botulinum toxin type A (BTX-A) combined with therapy can facilitate improved upper-extremity (UE) functional status versus therapy alone. ⋯ A focused therapy program showed the most improvement in function in this defined stroke population. BTX-A combined with a focused traditional therapy program slightly enhanced the functional status of stroke subjects beyond that obtained with therapy alone 12 weeks after injection.
-
Arch Phys Med Rehabil · Sep 2009
Clinical TrialEffect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.
To determine whether baseline hand spastic hemiparesis assessed by the Chedoke-McMaster Assessment influences functional improvement after botulinum toxin type A (BTX-A) injections and postinjection therapy. ⋯ BTX-A injections and postinjection therapy improved hand function and reduced spasticity for both Chedoke-McMaster Assessment Hand-Higher Function and Chedoke-McMaster Assessment Hand-Lower Function groups. Clinicians should expect to see larger gains for persons with less baseline impairment.
-
Arch Phys Med Rehabil · Sep 2009
Mortality over four decades after traumatic brain injury rehabilitation: a retrospective cohort study.
To investigate mortality, life expectancy, risk factors for death, and causes of death in persons with traumatic brain injury (TBI). ⋯ This study demonstrated life expectancy after TBI rehabilitation is reduced and associated with specific risk factors and causes of death.